Oxygen supplementation during air travel in patients with chronic obstructive lung disease
- B. W. Berg(corresponding author),
- T. A. Dillard,
- K. R. Rajagopal,
- W. J. Mehm
- Walter Reed Army Institute of Research
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewAbstract
<p>The objective of this study was to quantitate the effects of O<sub>2</sub> supplementation by nasal cannula (NC) and Venturi mask (VM) on PaO<sub>2</sub> in patients with chronic obstructive pulmonary disease (COPD) during acute hypobaric exposure, simulating a commercial jet aircraft cabin. We conducted a crossover intervention trial in which subjects served as their own controls in an ambulatory outpatient pulmonary disease service of a tertiary care military medical center and a hypobaric research facility. The subjects were a volunteer sample of 18 men with stable severe COPD, not requiring long-term O<sub>2</sub> therapy, and uncomplicated by hypercapnea or cardiac disease. Mean age was 68 years, and mean FEV<sub>1</sub> was 0.97 L (31.3 percent predicted). We exposed patients to conditions equivalent to 8,000 feet in a hypobaric chamber. Radial artery catheters provided blood samples at ground level and 8,000 feet. O<sub>2</sub> was sequentially administered at 8,000 feet by NC at 4 L/min and 24 percent or 28 percent VM. We describe changes in blood gas data from baseline values and between interventions. O<sub>2</sub> at 4 L/min NC flow at 8,000 feet caused PaO<sub>2</sub> to increase from 47.4 ± 6.3 mm Hg to 82.3 ± 14 mm Hg (n = 18), an increase of 34.9 ± 14.8 mm Hg. Supplementation of O<sub>2</sub> by 24 percent VM caused PaO<sub>2</sub> at 8,000 feet to increase by 12.7 ± 3.8 mm Hg. Twenty-eight percent VM caused PaO<sub>2</sub> at 8,000 feet to increase by 19.7 ± 8.2 mm Hg. Changes in PaO<sub>2</sub> with 4 L/min NC were greater than those with either VM. The increase with 28 percent VM was greater than that caused by 24 percent VM (P<0.05). Compared with ground level, 4 L/min NC increased mean PaO<sub>2</sub> by 9.9 ± 12.6 mm Hg; 24 percent and 28 percent VM did not cause mean PaO<sub>2</sub> to increase above ground level values. We describe a range of capability of familiar O<sub>2</sub> therapy devices to increase PaO<sub>2</sub> to levels that will maintain tissue oxygenation of patients during acute altitude exposure.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 638-641 (4 pages)Journal (Volume, Issue Number)
CHEST (Volume 101, Issue 3)Publication milestones
- Published - 1992
Publication status
Published - 1992
ISSN
0012-3692Publication IDs
- Scopus: 0026577280
- PubMed: 1541125
Publication metrics
Metrics
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Captures
24
Citation count
68
